EP2855424
METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.5.2013EP published:
11.10.2017EP application number:
13724708.6
EPO information:
European Patent Register
Max expiry date:
16.5.2033
Title:
METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE
Timeline
Today
17.5.2013EP application
11.10.2017EP Publication
Owner
Name:
Vanda Pharmaceuticals Inc.Address:
2200 Pennsylvania Avenue NW Suite 300, 20037, Washington, DC, US
Inventor
Name:
DRESSMAN, Marlene, MichelleAddress:
Germantown, MD, US
Name:
PHADKE, DeepakAddress:
Olathe, KS, US
Priority
Number:
201261649220 PDate:
18.5.2012Country:
US
Classification
Categories:
C07C 233/18, C07C 233/47, A61K 31/165, A61K 31/195, A61P 25/00, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/24, A61P 25/28